Q2 2025 Aptargroup Inc Earnings Call Transcript
Key Points
- AptarGroup Inc (ATR) delivered a strong second quarter, exceeding the high end of their guidance range with an adjusted earnings per share of $1.66, an 18% increase over the prior year.
- Core sales increased across all segments, with significant contributions from the Pharma and Closure segments.
- The acquisition of MOD Pharma's clinical trial manufacturing business is expected to expand AptarGroup Inc (ATR)'s capabilities in the CDMO field, supporting early-stage drug development.
- AptarGroup Inc (ATR) was named one of Time Magazine's World's Most Sustainable Companies for the second year in a row, highlighting their commitment to sustainability.
- The company has accelerated capital returns to shareholders, repurchasing approximately 1 million shares for about $150 million and returning $210 million through dividends and share repurchases.
- The Consumer Healthcare division continues to face challenges due to softer demand for dispensing technologies in nasal saline and nasal decongestants, particularly in Europe.
- Legal expenses related to litigation over intellectual property rights are expected to increase significantly, impacting future earnings.
- The beauty segment faced headwinds from trade uncertainties, affecting demand recovery in prestige fragrance dispensing technologies.
- The Pharma segment's growth is expected to slow down in the second half of the year due to uncertainties around naloxone sales and inventory levels.
- The effective tax rate for the second quarter was lower at 20.0%, but future tax benefits may not be as significant, potentially impacting net earnings.
Ladies and gentlemen, thank you for standing by and welcome to Aptar's 2025 second quarter results conference call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session.
Introducing today's conference call is Ms. Mary Skafidas, Senior Vice President, Investor Relations and Communications. Please go ahead, Mary.
Thank you. Hello, everyone and thanks for being with us today. Our speakers for the call are Stephan Tanda, our President and CEO; and Vanessa Kanu, our Executive Vice President and CFO. Our press release and accompanying slide deck have been posted on our website under the Investor Relations page.
During this call, we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure and the reconciliations are set forth in the press release. Please refer to the press release disseminated yesterday for reconciliations of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
